PracticesMedical Law
Practice area

Medical Law

Healthcare, pharmaceuticals and medical devices — clinical trials, marketing authorisation, reimbursement, promotion, data protection and product liability.

Contact us

The healthcare, pharmaceutical and medical devices sector is both heavily regulated and fast-moving, which makes specialist legal support essential.

Companies face daily requirements on clinical trials, marketing authorisation, pharmacovigilance and materiovigilance, pricing and reimbursement, advertising, public procurement, data protection and product liability.

We support manufacturers, importers, wholesalers, distributors, pharmacies, private healthcare institutions, and digital health and medtech companies in meeting those obligations, entering the market faster and growing safely.

The approach runs end to end: from R&D and clinical trials, through registration, pricing and reimbursement, to commercialisation, procurement and post-market obligations, in Serbian and English across the region.

Key practice areas

What we handle

Twelve areas of work across the product lifecycle.

01

Clinical trials and research

  • Documentation for regulatory approvals and ethics committees, and contracts with research centres, CROs, hospitals and universities.
  • Informed consent, protection of sensitive data, secondary use of health data and biobanking.
  • Compliance during the study: monitoring, adverse event flows, responsibilities and insurance.
  • Sponsor and investigator questions, including allocation of IP rights and publication of results.
02

Marketing authorisation and variations

  • Strategy and documentation for registration, wholesale and retail sale, parallel import and OTC/Rx status.
  • Variations, pharmacovigilance (PSUR, signal detection), labelling and packaging.
  • Monitoring of non-compliance and recalls, with communication to regulators and the public.
  • Advice on new medicine status, biosimilars and generics.
03

Pricing, margins and reimbursement

  • Preparation and management of reimbursement listing procedures.
  • Negotiation of models including risk-sharing and commercial agreements.
  • Compliance with price referencing, discounts, bonuses and transparency rules.
  • Analysis of how pricing policy affects market position and the sustainability of the model.
04

Advertising, promotion and HCP/HCO relations

  • Rules for Rx and OTC advertising, disease-awareness campaigns, samples, sponsorships and events.
  • HCP and HCO interactions: prohibitions, restrictions, reporting and internal policies.
  • Pre-launch review of campaign, brochure and digital materials.
05

Distribution, import/export and serialisation

  • Wholesale agreements, exclusivity and selective distribution, with GDP and GMP obligations built in.
  • Serialisation, traceability and technical and legal interoperability with the systems.
  • Allocation of supply chain responsibility and planning for supply disruption.
06

Medical devices and IVDs

  • Classification, compliance with standards, labelling and post-market surveillance.
  • Software as a medical device: intended use, updates, cybersecurity and user notifications.
  • Allocation of responsibility between manufacturer, authorised representative, distributor and importer.
  • MDR and IVDR transition and CE marking support.
07

e-Health, telemedicine and digital health

  • Telemedicine platforms, mHealth apps, wearables and integration with hospital systems.
  • Validation of data and medical functionality, terms of use, liability and informed consent in digital settings.
  • Certification and post-market obligations for software solutions.
08

Data protection and confidentiality

  • Health data as a special category: legal bases, DPIAs, minimisation, retention and security measures.
  • Clinical data, patient registries, real-world evidence and secondary use, with processor agreements and international transfers.
  • Alignment of contracts and procedures with GDPR.
  • Training and incident response plans for data breaches.
09

Intellectual property and technology transfer

  • Patents, trademarks, design protection and trade secrets, including SPCs and extensions in pharma.
  • Licensing, co-development and know-how agreements, due diligence and freedom-to-operate analysis.
  • Protection strategies integrated with the commercial agreements.
10

Public sector and procurement

  • Strategy for tenders in pharmaceuticals, devices and services: qualification, appeals and performance.
  • Public-private partnerships and pilot projects with healthcare institutions.
  • Assessment of exclusion and anti-corruption risk, with internal policies and mitigation plans.
11

Compliance, ethics and competition

  • Anti-corruption policies covering HCP and HCO interactions, gifts, travel and sponsorships.
  • Competition law: rebates, exclusivity, selective distribution, information exchange, concentrations and gun-jumping.
  • Internal whistleblowing procedures and investigations.
12

Product liability and disputes

  • Civil and regulatory liability, product liability disputes, insurance and recourse.
  • Recall strategies, corrective measures and communication with patients and professionals.
  • Representation in litigation, arbitration and settlement negotiations.
How we work

What working with us looks like

Four steps, from the first risk scan to ongoing maintenance.

01

Discovery and risk scan

A quick view of products, processes and objectives, identifying quick wins and critical gaps.

02

Plan and priorities

A regulatory and commercial roadmap with responsibilities and deadlines.

03

Implementation

Preparation and review of documents, negotiations, proceedings, training and SOPs.

04

Maintenance

Regulatory monitoring, template updates and response to inspections and incidents.

Track record

Selected matters

A sample of recent work in the sector.

Contracts

Trial and distribution agreements

CRO and site agreements, wholesale and distribution, licensing and technology transfer, processor agreements and sponsorship.

Regulatory

Dossiers and vigilance

Dossiers and variations, PSUR and PMCF, pharmacovigilance and materiovigilance SOPs, patient and HCP notices.

Policies

Promotion and privacy

Policies on advertising and HCP interactions, anti-corruption and transparency, data privacy and security, incident and recall playbooks.

Strategy

Market access

Market access and reimbursement strategy, IP and compliance due diligence, competition assessments and portfolio risk maps.

What Clients Ask Us Most

Can you prepare the full documentation for registration and variations?

Yes, including coordination with technical and regulatory teams, labelling compliance and communication with the regulator.

We prepare and track dossier submissions and variation strategies, and set the internal procedures that keep the documentation current.

Do you cover digital health and telemedicine?

Yes. We assess whether software qualifies as a medical device, draft terms of service, privacy and security requirements, and set post-market obligations.

We support certification, contracts with healthcare professionals and patients, and liability questions in medical error or technical incident scenarios, working to MDR, IVDR and GDPR.

Do you support procurement strategy and appeals?

Yes. We prepare the documentation, assess the risks and manage appeals.

We advise during qualification and evaluation, represent clients before the authorities and in court, and plan participation in framework agreements.

Do you train marketing, sales and medical representatives?

Yes — practical training, in-house or online, on advertising, promotion and HCP and HCO interactions.

Sessions cover the legal and ethical rules with case studies and inspection simulations, tailored from entry-level representatives to compliance officers.

How do you protect innovation and brands?

We combine patents and SPCs, trademarks and trade secrets with licensing agreements, and build IP and competition clauses into the commercial arrangements.

Beyond registration we enforce rights through due diligence, competitor monitoring and anti-counterfeit measures, and design commercialisation strategies through licensing, co-development or sale.

Next step

Let’s talk about your product or study

Tell us what you are registering, running or launching and we will map the regulatory path.

Contact us
Newsletter

Learn legal updates, and what to do about them

Legal developments in Serbia and the EU, each with the step it asks of your business.

Sign up

Two emails a month. Unsubscribe any time.